Long known as a messenger within cells, RNA is increasingly seen as life’s molecular communication system — even between ...

The data showed that a vaccine candidate produced positive immune responses against both A and B flu strains in younger and ...

Results from the first-in-human trial of a new mRNA-based cancer vaccine are promising, as are early results from two other ...

Aurora Biosynthetics, a pioneering advanced RNA therapeutics manufacturing company, announced its official launch. This ...

It all started in the lab. Two Boston University doctoral students, Joshua McGee and Jack Kirsch, were creating and testing ...

British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine ...

Moderna (MRNA) plans to launch a skin cancer vaccine developed with Merck (MRK) in 2025, but faces stock pressure after ...

GSK bought partner CureVac out of their alliance on influenza and COVID-19 vaccine development, boosting its messenger RNA credentials.

US mRNA-immunotherapy start-up Myeloid Therapeutics has launched Aurora Biosynthetics in Sydney to meet the Asia-Pacific ...

(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, and said it ...

An accidental discovery turned into an unexpected success when a team of interdisciplinary BU researchers created a new and ...